RFC
GEVA

Russell Frank Company’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Russell Frank Company’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-296
Closed -$29K – 3164
2015
Q1 		$29K Buy
+296
New +$31.3K ﹤0.01% 2854
2013
Q4 		– Sell
-2,575
Closed -$163K – 3353
2013
Q3 		$163K Sell
2,575
-79,614
-97% -$3.92M ﹤0.01% 2825
2013
Q2 		$3.45M Buy
+82,189
New +$3.75M 0.01% 1467

Russell Frank Company's GEVA Position: Q2 2015 in Review

Russell Frank Company sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 296 shares — an estimated $29K sold.

Russell Frank Company first reported a position in GEVA in Q2 2013 and held it in 3 quarters. The position peaked at $3.45M in Q2 2013. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Russell Frank Company reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Russell Frank Company sold 296 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $29K.
  • Russell Frank Company first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • Russell Frank Company's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $3.45M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.